High-Fat Diet–Induced DeSUMOylation of E4BP4 Promotes Lipid Droplet Biogenesis and Liver Steatosis in Mice
Diabetes · 01.03.2023 · 72 (3) · 348-361
DOI: 10.2337/db22-0332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, online erschienen am 12.12.2022. Verfasst von Sujuan Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI. Hauptthemen laut MEDLINE: Basic-Leucine Zipper Transcription Factors, Diet, High-Fat, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, national institute of health.
Abstract (Originalsprache)
Dysregulated lipid droplet accumulation has been identified as one of the main contributors to liver steatosis during nonalcoholic fatty liver disease (NAFLD). However, the underlying molecular mechanisms for excessive lipid droplet formation in the liver remain largely unknown. In the current study, hepatic E4 promoter–binding protein 4 (E4BP4) plays a critical role in promoting lipid droplet formation and liver steatosis in a high-fat diet (HFD)–induced NAFLD mouse model. Hepatic E4bp4 deficiency (E4bp4-LKO) protects mice from HFD-induced liver steatosis independently of obesity and insulin resistance. Our microarray study showed a markedly reduced expression of lipid droplet binding genes, such as Fsp27, in the liver of E4bp4-LKO mice. E4BP4 is both necessary and sufficient to activate Fsp27 expression and lipid droplet formation in primary mouse hepatocytes. Overexpression of Fsp27 increased lipid droplets and triglycerides in E4bp4-LKO primary mouse hepatocytes and restored hepatic steatosis in HFD-fed E4bp4-LKO mice. Mechanistically, E4BP4 enhances the transactivation of Fsp27 by CREBH in hepatocytes. Furthermore, E4BP4 is modified by SUMOylation, and HFD feeding induces deSUMOylation of hepatic E4BP4. SUMOylation of five lysine residues of E4BP4 is critical for the downregulation of Fsp27 and lipid droplets by cAMP signaling in hepatocytes. Taken together, this study revealed that E4BP4 drives liver steatosis in HFD-fed mice through its regulation of lipid droplet binding proteins. Our study also highlights the critical role of deSUMOylation of hepatic E4BP4 in promoting NAFLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI.
- Department of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, Hunan Province, People's Republic of China.
- Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong Province, People's Republic of China.
- Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, NJ.
- Department of Pharmacology, University of Virginia, Charlottesville, VA.
- Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI.
ORCID-Profile: Kezhong Zhang, Lei Yin, Xin Tong
Förderung
- NIDDK NIH HHS
- national institute of health
Zitieren
APA
Wang, S., Yang, M., Li, P., Sit, J., Wong, A., Rodrigues, K., Lank, D., Zhang, D., Zhang, K., Yin, L., & Tong, X. (2023). High-Fat Diet–Induced DeSUMOylation of E4BP4 Promotes Lipid Droplet Biogenesis and Liver Steatosis in Mice. Diabetes, 72(3), 348-361. https://doi.org/10.2337/db22-0332
Vancouver
Wang S, Yang M, Li P, Sit J, Wong A, Rodrigues K, et al. High-Fat Diet–Induced DeSUMOylation of E4BP4 Promotes Lipid Droplet Biogenesis and Liver Steatosis in Mice. Diabetes. 2023;72(3):348-361. doi:10.2337/db22-0332
BibTeX
@article{Wang2023,
author = {Wang, Sujuan and Yang, Meichan and Li, Pei and Sit, Julian and Wong, Audrey and Rodrigues, Kyle and Lank, Daniel and Zhang, Deqiang and Zhang, Kezhong and Yin, Lei and Tong, Xin},
title = {High-Fat Diet–Induced DeSUMOylation of E4BP4 Promotes Lipid Droplet Biogenesis and Liver Steatosis in Mice},
journal = {Diabetes},
year = {2023},
volume = {72},
number = {3},
pages = {348--361},
doi = {10.2337/db22-0332}
}
EUVIMED